YeonSoo Jang

• Specialized in clinical development and gap assessment of technical documentation - determine the best way to present information in assigned regulatory submissions to maximize reviewability by global health authorities
• Expanded business through strategic partnerships with global CRO companies
• Identified new business opportunities and spearheaded strategic alliances

[Business performance and Investor Communication]

• Prepared and reviewed quarterly business performance reports, ensuring accuracy and comprehensiveness
• Planned and communicated business performance and strategic plans to investors, maintaining transparency and fostering trust

[Strategic Planning and Market Analysis]

• Developed and implemented corporate-level strategies for C-level executive decision-making
• Formulated and documented initiative roadmaps as part of business plan implementation
• Conducted comprehensive market research, including target market and competitor analysis, to inform business objectives

[Contents Lab]

• Identified, sourced, and curated data and content required for training AI models, ensuring high-quality inputs for optimal model performance
• Developed strategies and plans for collecting speech data required for training models for 1:1 general AI tutor product

[Team Leadership and Project Management:]

• Led small teams and project stakeholders to ensure alignment and effective execution of business initiatives
• Collected and analyzed project-specific information to solve various business issues
• Prepared detailed reports and presentations for executive-level meetings, ensuring clear communication of strategic recommendations
• Collaborated with AI researchers and engineers in cross-functional teams to drive innovation and ensure project success

[Global Clinical Development & Project Management]

• Led the clinical development of a diabetic retinopathy candidate in Korea, including the development of the Investigator’s Brochure & Protocol, and successfully filed with and received approval from the MFDS
• Directed the Phase IIb clinical development of a diabetic retinopathy candidate in the US, including the development of the Investigator’s Brochure & Protocol, and successfully managed submissions and meetings with the US FDA
• Managed overseas clinical studies for the Herpes Zoster vaccine, including the development of the Investigator’s Brochure & Protocol, and successfully managed IND/CTD submissions, ensuring regulatory compliance and securing approvals

[Project Management]

• Managed Technical Transfer Project for Medical Device (ISO13485:2016) achieving US FDA and CE MDR approvals
• Oversaw scale-up study, including protocol and report reviews, process development and establishment

[Business Development]

• Licensing in/out
• Represented the company as the primary presenter to biopharmaceutical experts and overseas Key Opinion Leaders- delivered company introduction, enhancing company visibility and fostering key industry relationships
• Screened potential business deals by analyzing deal requirements, evaluating options, recommending equity investment
• Commercialization of new product in US and EU from preclinical to commercial launch. (Licensing agreement with Allergan Inc., 65mln upfront, an aggregate of USD116mln for development milestones, up to USD180mln for commercialization milestones, and royalties on product sales)

[Product Development]

• Involved in Botulinum Toxin Products (Liquid & Lyophilized) CMC Development
• New Project (Osteoarthritis: OA viscosupplementation; USD0.9mln Project) TFT Member
• BioStar Project: Received USD3.7mln government investment to develop a new product

[Clinical Development]

• Developed Investigator’s Brochure
• Involved in Clinical Studies in overseas

• Project on Molecular and Cellular Pathogenesis of Listeria infection